
Sarissa tightens its grip on Amarin as CEO resigns
Sarissa Capital gained another foothold in its takeover of Amarin with the departure of the Irish drugmaker’s CEO.
Amarin revealed Friday in an SEC filing that Karim Mikhail resigned as president and CEO earlier this week. However, there’s still an ongoing dispute between Mikhail and Amarin, with the now ex-CEO insisting that he has a claim to severance as a result of his resignation. However, Amarin says it disagrees and plans to dispute that claim.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.